Genital, Oral, and Anal Type-specific Human Papillomavirus Concordance within Individuals and between Partners.

IF 3.4 3区 医学 Q2 ONCOLOGY Cancer Epidemiology Biomarkers & Prevention Pub Date : 2025-06-03 DOI:10.1158/1055-9965.EPI-24-1843
Alissa Moore, Mariam El-Zein, Ann N Burchell, Pierre-Paul Tellier, François Coutlée, Eduardo L Franco
{"title":"Genital, Oral, and Anal Type-specific Human Papillomavirus Concordance within Individuals and between Partners.","authors":"Alissa Moore, Mariam El-Zein, Ann N Burchell, Pierre-Paul Tellier, François Coutlée, Eduardo L Franco","doi":"10.1158/1055-9965.EPI-24-1843","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Studying human papillomavirus (HPV) genotype concordance between male and female partners and between multiple anatomic sites can help our understanding of HPV epidemiology.</p><p><strong>Methods: </strong>Heterosexual couples ages 18+ formed within the past 6 months attended visits at 0, 2, 4, 6, 9, and 12 months. They answered questionnaires and provided genital, oral, and anal samples for HPV genotyping. We calculated observed/expected (O/E) concordance [with 95% confidence intervals (CI)] between anatomic sites of HPV genotype-specific infections across all visits and cumulatively (i.e., ever-positivity). We used mixed-effects logistic regression with random intercepts at the person level to estimate ORs for concordance and to assess predictors of genital HPV detection and partner concordance.</p><p><strong>Results: </strong>Within-individual O/E genital/anal concordance was 23.37 (CI, 15.55-38.05) for females and 14.79 (CI, 9.20-43.45) for males, whereas genital/genital O/E concordance between partners was 14.99 (CI, 12.47-18.41). Genital/genital concordance for ever-positivity within couples was substantial: O/E: 10.06 (CI, 8.55-12.12), with ORs of 70.75 (CI, 43.70-114.56) for females and 67.34 (CI, 41.96-108.06) for males. Significant predictors of genital ever-positivity were one's partner's ever-positivity, ORs of 66.2 (CI, 40.96-107.08) in females and 61.53 (CI, 38.19-99.14) in males, and age above the median in females and males, ORs of 1.66 (CI, 1.06-2.59) in females and 1.95 (CI, 1.30-2.91) in males. Concordance doubled (OR, 1.96; CI, 1.12-3.46) with occasions of intimacy above the median.</p><p><strong>Conclusions: </strong>We observed substantial genital/anal concordance within individuals (particularly females) and genital/genital concordance between partners. Certain sociodemographic and behavioral factors influenced concordance.</p><p><strong>Impact: </strong>Findings shed light on HPV natural history and transmissibility.</p>","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":" ","pages":"850-859"},"PeriodicalIF":3.4000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology Biomarkers & Prevention","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1055-9965.EPI-24-1843","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Studying human papillomavirus (HPV) genotype concordance between male and female partners and between multiple anatomic sites can help our understanding of HPV epidemiology.

Methods: Heterosexual couples ages 18+ formed within the past 6 months attended visits at 0, 2, 4, 6, 9, and 12 months. They answered questionnaires and provided genital, oral, and anal samples for HPV genotyping. We calculated observed/expected (O/E) concordance [with 95% confidence intervals (CI)] between anatomic sites of HPV genotype-specific infections across all visits and cumulatively (i.e., ever-positivity). We used mixed-effects logistic regression with random intercepts at the person level to estimate ORs for concordance and to assess predictors of genital HPV detection and partner concordance.

Results: Within-individual O/E genital/anal concordance was 23.37 (CI, 15.55-38.05) for females and 14.79 (CI, 9.20-43.45) for males, whereas genital/genital O/E concordance between partners was 14.99 (CI, 12.47-18.41). Genital/genital concordance for ever-positivity within couples was substantial: O/E: 10.06 (CI, 8.55-12.12), with ORs of 70.75 (CI, 43.70-114.56) for females and 67.34 (CI, 41.96-108.06) for males. Significant predictors of genital ever-positivity were one's partner's ever-positivity, ORs of 66.2 (CI, 40.96-107.08) in females and 61.53 (CI, 38.19-99.14) in males, and age above the median in females and males, ORs of 1.66 (CI, 1.06-2.59) in females and 1.95 (CI, 1.30-2.91) in males. Concordance doubled (OR, 1.96; CI, 1.12-3.46) with occasions of intimacy above the median.

Conclusions: We observed substantial genital/anal concordance within individuals (particularly females) and genital/genital concordance between partners. Certain sociodemographic and behavioral factors influenced concordance.

Impact: Findings shed light on HPV natural history and transmissibility.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生殖器、口腔和肛门型特异性人乳头瘤病毒在个体和伴侣之间的一致性。
背景:研究人乳头瘤病毒(HPV)在男性和女性伴侣之间以及多个解剖位点之间的基因型一致性有助于了解HPV流行病学。方法:在过去6个月内形成的18岁以上的异性恋夫妇在0、2、4、6、9和12个月时进行了访问。他们回答了调查问卷,并提供了生殖器、口腔和肛门的HPV基因分型样本。我们计算了HPV基因型特异性感染解剖部位之间的观察/预期(O/E)一致性(95%可信区间[CI]),包括所有就诊和累积(即永远阳性)。我们使用混合效应逻辑回归,在个人水平上随机截取,以估计一致性的优势比(OR),并评估生殖器HPV检测和伴侣一致性的预测因素。结果:个体内O/E女性为23.37 (CI: 15.55 ~ 38.05),男性为14.79 (CI: 9.20 ~ 43.45),而性伴侣之间的O/E一致性为14.99 (CI: 12.47 ~ 18.41)。夫妻中一直呈阳性的生殖器官/生殖器官的一致性是显著的:女性的O/E为10.06 (CI: 8.55-12.12), OR为70.75 (CI: 43.70-114.56),男性为67.34 (CI: 41.96-108.06)。生殖器永远阳性的显著预测因子为伴侣的永远阳性,女性的OR值为66.2 (CI: 40.96-107.08),男性的OR值为61.53 (CI: 38.19-99.14);男性和女性的年龄高于中位数,女性的OR值为1.66 (CI: 1.06-2.59),男性的OR值为1.95 (CI: 1.30-2.91)。在亲密场合高于中位数时,一致性翻倍(OR: 1.96, CI: 1.12-3.46)。结论:我们观察到个体(尤其是女性)和伴侣之间生殖器/生殖器的一致性。某些社会人口和行为因素影响一致性。影响:研究结果揭示了HPV的自然史和传播性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer Epidemiology Biomarkers & Prevention
Cancer Epidemiology Biomarkers & Prevention 医学-公共卫生、环境卫生与职业卫生
CiteScore
6.50
自引率
2.60%
发文量
538
审稿时长
1.6 months
期刊介绍: Cancer Epidemiology, Biomarkers & Prevention publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; implementation science and cancer care delivery; and the science of cancer health disparities. Besides welcoming manuscripts that address individual subjects in any of the relevant disciplines, CEBP editors encourage the submission of manuscripts with a transdisciplinary approach.
期刊最新文献
Urinary Levels of Endocrine-Disrupting Chemicals and Breast Density in Young Women. Evaluating Efficacy of Cervical HPV-HR DNA Testing as Alternative to PET/CT Imaging for Posttreatment Cancer Surveillance: Retrospective Proof-of-Concept Study. Food Insecurity and Clinical Biomarkers of Inflammation among Cancer Survivors in the All of Us Research Program. Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors. Rurality of Residence and Distance to Clinic Are Risk Factors for Non-engagement in Childhood Cancer Survivor Care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1